Log in

OTCMKTS:EMITFElbit Imaging Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $1.00
50-Day Range
MA: $1.16
52-Week Range
Now: $1.00
Volume25,042 shs
Average Volume6,573 shs
Market Capitalization$9.19 million
P/E RatioN/A
Dividend YieldN/A
Elbit Imaging Ltd., together with its subsidiaries, engages in medical industries and plots sale businesses in India, and Central and Eastern Europe. It is involved in the research and development, production, and marketing of treatment-oriented medical systems, including magnetic resonance imaging for the purpose of performing noninvasive treatments in human beings; and products designated for certain cancer diseases. The company was founded in 1996 and is headquartered in Petach Tikva, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.72 out of 5 stars

Industry, Sector and Symbol

Industry Nonresidential building operators



Sales & Book Value

Annual Sales$22.73 million
Cash Flow$4.55 per share
Book Value($1.75) per share



Market Cap$9.19 million
Next Earnings DateN/A
OptionableNot Optionable

Receive EMITF News and Ratings via Email

Sign-up to receive the latest news and ratings for EMITF and its competitors with MarketBeat's FREE daily newsletter.

Elbit Imaging (OTCMKTS:EMITF) Frequently Asked Questions

How has Elbit Imaging's stock been impacted by COVID-19 (Coronavirus)?

Elbit Imaging's stock was trading at $1.36 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, EMITF shares have decreased by 26.5% and is now trading at $1.00. View which stocks have been most impacted by Coronavirus.

Has Elbit Imaging been receiving favorable news coverage?

Media headlines about EMITF stock have been trending negative recently, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Elbit Imaging earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave media headlines about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about Elbit Imaging.

Who are some of Elbit Imaging's key competitors?

Who are Elbit Imaging's key executives?

Elbit Imaging's management team includes the following people:
  • Mr. Ron Hadassi BA, LL.B, MBA, CEO & Chairman of Directors (Age 53)
  • Dr. Maurice R. Ferré, Chairman & CEO of Insightec Ltd (Age 57)
  • Mr. Jun Tao, Chief Commercial Officer of InSightec Ltd (Age 52)
  • Ms. Yael Naftali, Chief Financial Officer (Age 39)
  • Tal Shani, Corp. Sec.

What is Elbit Imaging's stock symbol?

Elbit Imaging trades on the OTCMKTS under the ticker symbol "EMITF."

How do I buy shares of Elbit Imaging?

Shares of EMITF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Elbit Imaging's stock price today?

One share of EMITF stock can currently be purchased for approximately $1.00.

How big of a company is Elbit Imaging?

Elbit Imaging has a market capitalization of $9.19 million and generates $22.73 million in revenue each year.

What is Elbit Imaging's official website?

The official website for Elbit Imaging is www.elbitimaging.com.

How can I contact Elbit Imaging?

Elbit Imaging's mailing address is 3 SHIMSHON STREET, PETACH TIKVA L3, 4900102. The financial services provider can be reached via phone at 972-3608-6000 or via email at [email protected]

This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.